QUILSECONAZOLE, VT 1129, New Patent, WO, 2017049080, Viamet

VT 1129 BENZENE SULFONATE

CAS 1809323-18-9

VT 1129

1340593-70-5 CAS

MF C22 H14 F7 N5 O2, MW 513.37

2-Pyridineethanol, α-(2,4-difluorophenyl)-β,β-difluoro-α-(1H-tetrazol-1-ylmethyl)-5-[4-(trifluoromethoxy)phenyl]-, (αR)-

R ISOMER

ROTATION +

QUILSECONAZOLE, VT-1129

Viamet, in collaboration with Therapeutics for Rare and Neglected diseases, is investigating quilseconazole benzenesulfonate (VT-1129), a small-molecule lanosterol demethylase (CYP51) inhibitor, developed using the company's Metallophile technology, for treating fungal infections, including Cryptococcus neoformans meningitis.

WO-2017049080

  

////////////QUILSECONAZOLE, VT-1129, New Patent, WO, 2017049080, Viamet